Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors

4 Mar 2020

Abstract excerpt

Indications for current immune checkpoint inhibitors are expanding and now include thymic epithelial tumors (TETs). Although clinical trials on immune checkpoint inhibitors for TETs are ongoing, a rationale has not yet been established for immunotherapy for TETs. Therefore, we herein performed phenotypic and functional analyses of T cells in surgically resected TET tissues with a focus on the anti-tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Myasthenia Gravis and Thymoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32132638
DOI: 10.1038/s41598-020-61053-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumorsPMID 32132638Read ↗

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial TumorsSemantic proximity Read ↗

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.Semantic proximity Read ↗

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.Semantic proximity Read ↗

Single-Cell Sequencing Illuminates Thymic Development: An Updated Framework for Understanding Thymic Epithelial TumorsSemantic proximity Read ↗

Thymic epithelial tumors: From biology to treatment.Semantic proximity Read ↗

Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signaturesSemantic proximity Read ↗

Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy.Semantic proximity Read ↗

Prognostic analysis of tumor mutation burden combined with immune infiltration of Thymic epithelial tumorsSemantic proximity Read ↗

Deciphering the biology of thymic epithelial tumorsSemantic proximity Read ↗

The Prognostic Value of Tumor Mutation Burden and Immune Cell Infiltration in Thymic Epithelial Tumors.Semantic proximity Read ↗

Point of view: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.Semantic proximity Read ↗

Molecular predictors of response to pembrolizumab in thymic carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.